News for Synlogic, Inc. (SYBX)

Synlogic, Inc. (SNDX) is set to participate in a meeting organized by B. Riley in New York on May 19. This engagement forms part of the company's strategy to sh

Explore the exciting IPOs of 2023 and learn how these companies are shaping the stock market.

**media[464145]**

Synlogic's head of finance Mary Beth Dooley sells $110 in stock

The Oxygen Scavenger growth is primarily fueled by the increasing demand for oxygen scavengers in food packaging, and pharmaceuticals, aimed at enhancing...

Eliem completed the acquisition of Tenet Medicines and concurrent $120 million private placement Eliem to host an Investor Day later in the year to...

WINCHESTER, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform...

Eliem Therapeutics EVP sells $338,000 in stock

WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and...

Synlogic, Inc. (NASDAQ: SYBX) came out with a quarterly loss of $1.71 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $3.60 per share a year ago. These figures are adjusted for non-recurring items.

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of -54.05% and 2.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform...

Engages Ladenburg Thalmann as financial advisor to assist with previously announced strategic review process...

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.14%

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

U.S. stocks traded mixed this morning, with the S&P 500 topping the 5,000 mark on Friday. Following the market opening Friday, the Dow traded down 0.05% to 38,706.33 while the NASDAQ rose 0.32% to 15,844.63. The S&P 500 also rose, gaining, 0.11% to 5,003.51.

Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies...

/PRNewswire/ -- The urea cycle disorder treatment market size is expected to grow by USD 235.5 million from 2022 to 2027. In addition, the momentum of the...

/PRNewswire/ -- The "Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer,...